Drug – bio-affecting and body treating compositions – Lymphokine – Interferon
Reexamination Certificate
2005-11-15
2005-11-15
Andres, Janet (Department: 1646)
Drug, bio-affecting and body treating compositions
Lymphokine
Interferon
C424S085400, C530S351000
Reexamination Certificate
active
06964761
ABSTRACT:
A method of treating idiophathic pulmonary fibrosis (IPF), comprising administering aerosolized interferon-γ in a therapeutically effective amount to achieve improved or ameliorated symptoms of IPF.
REFERENCES:
patent: 5284656 (1994-02-01), Platz et al.
patent: 2001/0043906 (2001-11-01), Vlasselaer et al.
patent: WO 01/36001 (2001-05-01), None
Gross et al. New England J. Med. 2001, vol. 345(7), pp. 517-525.
Ziesche et al., 1999, N. Eng. J. Med. 341:1264-1269.
Adjei et al., 1990, Pharm. Res., 7:565-569.
Sjodin, L. et al., 1990, Int'l. J. of Pharm., 63:135-144.
Hubbard et al., 1989, A. of Inter. Med., 3;206-212.
Smith et al., 1989, J. Clin. Invest., 84:1145-1146.
Rany Condos et al, IPF: Definition and Diagnosis, NYU School of Medicine Pulmonary and Critical Care Division Grand Rounds, Apr. 6, 2005.
American Thoracic Society, Idiopathic Pulmonary Fibrosis: Diagnosis and Treatment, Am J Respir Crit Care Med, vol. 161, pp. 646-664, 2000.
Condos Rany
Rom William
Smaldone Gerald
Andres Janet
Klauber & Jackson
New York University
The Research Foundation of the State University of New York
LandOfFree
Method of treating idiopathic pulmonary fibrosis with... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Method of treating idiopathic pulmonary fibrosis with..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method of treating idiopathic pulmonary fibrosis with... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3492983